Is oral vitamin D a risk factor for prosthetic loosening?

Acta Orthopaedica Belgica

Volumn 75, Issue 1, 2009, Pages 2-7

  Peersman, Geert ^a   Bellemans, Johan ^a,b   Richart, Tom ^a,b  

^a ZiekenhuisNetwerk Antwerpen   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Extrarenal activation; Joint replacement surgery; Loosening; Macrophages; Metabolic syndrome; Particles; Prosthesis; Vitamin D; Wear

Indexed keywords

COLONY STIMULATING FACTOR 1; VITAMIN D;

HUMAN; JOINT PROSTHESIS; MACROPHAGE; METABOLISM; ORAL DRUG ADMINISTRATION; PROSTHESIS FAILURE; REVIEW; RISK FACTOR;

ADMINISTRATION, ORAL; HUMANS; JOINT PROSTHESIS; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; PROSTHESIS FAILURE; RISK FACTORS; VITAMIN D;

EID: 62149115740     PISSN: 00016462     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Abreu MT, Kantorovich V, Vasiliauskas EA et al. Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25dihydroxyvitamin D and low bone mineral density. Gut 2004; 53: 1129-1136.
2. Asomaning K, Bertone-Johnson ER, Nasca PC, Hooven F, Pekow PS. The association between bodymass index and osteoporosis in patients referred for a bone mineral density examination. J Womens Health 2006; 15: 1028-1034.
3. Bonaccorsi L, Marchiani S, Ferruzzi P et al. Non-genomic effects of the androgen receptor and Vitamin D agonist are involved in suppressing invasive phenotype of prostate cancer cells. Steroids 2006; 71: 304-309.
4. Bosch X. Hypercalcemia due to endogenous overproduction of 1,25-dihydroxyvitamin D in Crohn's disease. Gastroenterology 1998; 114: 1061-1065.
5. Cai X, Wang J, Hu Y, Lu S, Li N, Huang J. [Effect of wear particles on cell-to-cell communication of synoviocyte system in vitro and its significance in aseptic loosening of prosthesis] (in Chinese). Zhonghua Wai Ke Za Zhi 1999; 37: 406-408.
6. Clemens TL, Zhou XY, Myles M, Endres D, Lindsay R. Serum vitamin D2 and vitamin D3 metabolite concentrations and absorption of vitamin D2 in elderly subjects. J Clin Endocrinol Metab 1986; 63: 656-660.
7. De Boland AR, Boland RL. Non-genomic signal transduction pathway of vitamin D in muscle. Cell Signal 1994; 6: 717-724.
8. Hatun S, Cizmecioglu F. Use of alendronate in the treatment of vitamin D intoxication in infants. Turk J Pediatr 2005; 47: 373-375.
9. Hewison M, Zehnder D, Chakraverty R, Adams JS. Vitamin D and barrier function: a novel role for extra-renal 1 alpha-hydroxylase. Mol Cell Endocrinol 2004; 215 (1-2): 31-38.
10. Horowitz SM, Rapuano BP, Lane JM, Burstein AH. The interaction of the macrophage and the osteoblast in the pathophysiology of aseptic loosening of joint replacements. Calcif Tissue Int 1994; 54: 320-324.
11. Ishinii Y, Miyaura C, Jin CH et al. IL-6 is produced by osteoblasts and induces bone resorption. J. Immunol 1990; 145: 3297-3303.
12. Izaks GJ. Fracture prevention with Vitamin D supplementation: Considering the inconsistent results. BMC Musculoskeletal Disorders 2007; 236: 1-8.
13. Jin QH, Lu HS, Chen ZK, Jiang DF, Wang YH. [Significance and role of increased expression of extracellular matrix metalloproteinase induced in the aseptic loosening of prostheses.] (in Chinese). Zhonghua Wai Ke Za Zhi 2004; 42: 1232-1235.
14. Kerr DNS. Hypercalcemia and metastatic calcification. Cardiovasc Res 1997; 36: 293-297.
15. Kolundzic R, Orlic D, Trkulja V, Pavelic K, Troselj KG. Single nucleotide polymorphisms in the interleukin-6 gene promoter, tumor necrosis factor-alpha gene promoter, and transforming growth factor-beta 1 gene signal sequence as predictors of time to onset of aseptic loosening after total hip arthroplasty: preliminary study. J Orthop Sci 2006; 11: 592-600.
16. Konttinen YT, Xu JW, Waris E et al. Interleukin-6 in aseptic loosening of total hip replacement prostheses. Clin Exp Rheumatol 2002; 20: 485-490.
17. Lal H, Pandey R, Aggarwal SK. Vitamin D: non-skeletal actions and effects on growth. Nutrition Research 1999; 19: 1683-1718.
18. Lee DC, Lee GY. The use of pamidronate for hypercalcemia secondary to acute vitamin D intoxication. J Toxicol Clin Toxicol 1998; 36: 719-721.
19. Li TF, Xu JW, Santavirta S et al. Distribution of fibronectins and their integrin receptors in interface tissue from aseptic loosening of hip prostheses. Clin Exp Rheumatol 2000; 18: 221-225.
20. Miller MD, Peters CL, Allen B. Early aseptic loosening of a total knee arthroplasty due to Gore-Tex particle-induced osteolysis. J Arthroplasty 2006; 21: 765-770.
21. Miyaura C, Inada M, Matsumoto C et al. An essential role of cytosolic phospholipase A2alpha in prostaglandin E2-mediated bone resorption associated with inflammation. J Exp Med 2003; 197: 1303-1310.
22. Nguyen TV, Center JR, Eisman JA. Osteoporosis in elderly men and women: effects of dietary calcium, physical activity, and body mass index. J Bone Miner Res 2000; 15: 322-31.
23. Noguera A, Ros JB, Pavia C et al. Bisphosphonates, a new treatment for glucocorticoid-induced osteoporosis in children. J Pediatr Endocrinol Metab 2003; 16: 529-36.
24. Ohlin A, Lerner UH. Bone-resorbing activity of different periprosthetic tissues in aseptic loosening of total hip arthroplasty. Bone Miner 1993; 20: 67-78.
25. Orbak Z, Doneray H, Keskin F et al. Vitamin D intoxication and therapy with alendronate (case report and review of literature). Eur J Pediatr 2006; 165: 583-584.
26. Otto M, Kriegsmann J, Gehrke T, Bertz S. [Wear particles: key to aseptic prosthetic loosening ?] (in German). Pathologe 2006; 27: 447-460.
27. Pollice PF, Rosier RN, Looney RJ et al. Oral pentoxifylline inhibits release of tumor necrosis factor-alpha from human peripheral blood monocytes: a potential treatment for aseptic loosening of total joint components. J Bone Joint Surg 2001; 83-A: 1057-1061.
28. Prosser DE, Jones G. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci 2004; 29: 664-73.
29. Quinn JM, Elliott J, Gillespie MT, Martin TJ. A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro. Endocrinology 1998; 139: 4424-4427.
30. Rachez C, Freedman LP. Mechanisms of gene regulation by vitamin D(3) receptor: a network of coactivator interactions. Gene 2000; 246: 9-21.
31. Romas E, Gillespie MT, Martin TJ. Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. Bone 2002; 30: 340-346.
32. Sabokbar A, Fujikawa Y, Neale S, Murray DW, Athanasou NA. Human arthroplasty derived macrophages differentiate into osteoclastic bone resorbing cells. Ann Rheum Dis 1997; 56: 414-420.
33. Sabokbar A, Itonaga I, Sun SG, Kudo O, Athanasou NA. Arthroplasty membrane-derived fibroblasts directly induce osteoclast formation and osteolysis in aseptic loosening. J Orthop Res 2005; 23: 511-519.
34. Smith SJ, Hayes ME, Selby PL, Mawer EB. Autocrine control of vitamin D metabolism in synovial cells from arthritic patients. Ann Rheum Dis 1999; 58: 372-378.
35. Streich NA, Breusch SJ, Schneider U. Serum levels of interleukin 6 (IL-6), granulocyte-macrophage colony-stimulating factor (GM-CSF) and elastase in aseptic prosthetic loosening. Int Orthop 2003; 27: 267-271.
36. Takada J, Imoto K, Iba K, Yamashita T. [Adequate treatment with bisphosphonates for senile osteoporosis.] (in Japanese). Nippon Rinsho 2006; 64: 1657-1661.
37. Takeuchi Y. [How do bisphosphonates improve bone quality?] (in Japanese). Clin Calcium 2004; 14: 627-631.
38. Tanaka R, Yasunaga Y, Hisatome T et al. Serum interleukin 8 levels correlate with synovial fluid levels in patients with aseptic loosening of hip prosthesis. J Arthroplasty 2005; 20: 1049-1054.
39. Tatakis DN. Interleukin-1 and bone metabolism: a review. J Periodontol 1993; 64 (5 Suppl): 416-431.
40. Tauber C, Noff M, Noff D, Malkin C. Active metabolites of vitamin D in patients with coxarthrosis and with aseptic loosening of total hip endoprostheses. Arch Orthop Trauma Surg 1989; 108: 176-178.
41. Viale PH, Sanchez YD. Bisphosphonates: expanded roles in the treatment of patients with cancer. Clin J Oncol Nurs 2003; 7: 393-401.
42. Wise LM, Waldman SD, Kasra M et al. Effect of zoledronate on bone quality in the treatment of aseptic loosening of hip arthroplasty in the dog. Calcif Tissue Int 2005; 77: 367-375.
43. Xu JW, Konttinen YT, Waris V et al. Macrophage-colony stimulating factor (M-CSF) is increased in the synovial-like membrane of the periprosthetic tissues in the aseptic loosening of total hip replacement (THR). Clin Rheumatol 1997; 16: 243-248.
44. Zehnder D, Hewison M. The renal function of 25-hydroxy-vitamin D3-lalpha-hydroxylase. Mol Cell Endocrinol 1999; 151: 213-220.